Christina Brennan, MD, MBA, FACRP, is senior vice president of clinical research at The Feinstein Institutes for Medical Research at Northwell Health.
A Close Look at Clinical Trials in Oncology and Beyond: Looking Toward the Future
In this last episode, experts underscore the importance of incorporating the patient voice into clinical trial processes.
Read More
A Close Look at Clinical Trials in Oncology and Beyond: Efforts at Northwell
In this episode, experts discuss the growth and strategic development of Northwell's cancer clinical trial programs.
A Close Look at Clinical Trials in Oncology and Beyond: Leveraging AI
In this episode, experts discuss how artificial intelligence tools can enhance clinical trial recruitment, improve workforce efficiency, and more.
A Close Look at Clinical Trials in Oncology and Beyond: Recruitment and Inclusion
In this episode, experts highlight the increasing push to simplify cancer trial eligibility criteria and improve diversity in participant enrollment.
A Close Look at Clinical Trials in Oncology and Beyond: State of Affairs and Industry Progress
In this episode, experts discuss progress in cancer clinical trials and the challenges posed by the increasing complexity of therapies and protocols.
A Close Look at Clinical Trials in Oncology and Beyond: Boosting Accessibility
In this episode, experts emphasize the importance of providing flexible clinical trial options, such as satellite sites and remote follow-ups.
A Close Look at Clinical Trials in Oncology and Beyond: Barriers to Participation
In this episode, experts discuss the challenges of increasing awareness and participation in clinical trials.
A Close Look at Clinical Trials in Oncology and Beyond: Incorporating Into Standard Care
In this episode, experts discuss the importance of integrating clinical trials as a standard of care, particularly in the realm of oncology.
Dr Oluwole on CRS and Neurotoxicity Beyond 2 Weeks After Axi-Cel Infusion in R/R LBCL
Dr Garfall on Ide-Cel and Lenalidomide Maintenance in Myeloma After Suboptimal ASCT Response
Piflufolastat F18 Imaging Is Associated With High Clinician Confidence in Prostate Cancer Management
OPTYX Study Offers Preliminary Glance Into Real-World Use of Relugolix in Advanced Prostate Cancer